6505--Dimethyl Fumarate Capsules

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NAC PHARMACEUTICALS (36E797)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36E79726R0003

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
This procurement notice announces the award for the supply of Dimethyl Fumarate Capsules, classified under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing), with Product Service Code 6505. The contract is managed by the National Acquisition Center (NAC) Pharmaceuticals office, a division of the Department of Veterans Affairs (VA). The primary objective of this procurement is to ensure a reliable and consistent supply of Dimethyl Fumarate Capsules, a pharmaceutical product essential for the VA’s healthcare delivery to veterans. The scope of this contract encompasses the manufacturing and delivery of Dimethyl Fumarate Capsules in accordance with federal pharmaceutical standards and VA requirements. The intended outcome is to maintain an uninterrupted supply chain of this medication, supporting the VA’s mission to provide high-quality healthcare services to veterans nationwide. Contractors are expected to adhere to stringent quality assurance protocols, regulatory compliance, and timely fulfillment of orders as specified by the VA. Key requirements for this procurement include the capability to manufacture pharmaceutical-grade Dimethyl Fumarate Capsules, compliance with all applicable FDA regulations, and the ability to deliver products to VA facilities as needed. The awarded contractor must demonstrate robust manufacturing processes, quality control measures, and a proven track record in pharmaceutical supply to federal agencies. The contracting entity for this award is NAC Pharmaceuticals (36E797), operating under the Department of Veterans Affairs. The primary point of contact for this procurement is Kenneth Lay, who can be reached via email at [email protected] or by phone at (708) 786-4879. The notice remains active as of the posting date, March 18, 2026, and further details can be accessed through the official SAM.gov opportunity listing. This procurement is categorized as an award notice, indicating that the contract has been finalized and is now in the execution phase. Contractors interested in similar future opportunities should note the federal classification codes and the VA’s emphasis on regulatory compliance, product quality, and reliable delivery. No specific set-aside requirements or special considerations are indicated in the provided information. Overall, this contract represents a critical component of the VA’s pharmaceutical supply chain, ensuring that essential medications like Dimethyl Fumarate Capsules are available to support the health and well-being of veterans across the United States.